ATE227346T1 - Verfahren zur spezifischen kopplung einer schutzgruppe an das 5'-ende eines mrna-fragmentes und die herstellung von mrna und vollständiger cdna - Google Patents

Verfahren zur spezifischen kopplung einer schutzgruppe an das 5'-ende eines mrna-fragmentes und die herstellung von mrna und vollständiger cdna

Info

Publication number
ATE227346T1
ATE227346T1 AT96914259T AT96914259T ATE227346T1 AT E227346 T1 ATE227346 T1 AT E227346T1 AT 96914259 T AT96914259 T AT 96914259T AT 96914259 T AT96914259 T AT 96914259T AT E227346 T1 ATE227346 T1 AT E227346T1
Authority
AT
Austria
Prior art keywords
mrna
pct
fragment
protection group
complete cdna
Prior art date
Application number
AT96914259T
Other languages
English (en)
Inventor
Irena Nicolaevna Merenkova
Milne Edwards Jean-Bapti Dumas
Original Assignee
Genset Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9505221A external-priority patent/FR2733765B1/fr
Application filed by Genset Sa filed Critical Genset Sa
Application granted granted Critical
Publication of ATE227346T1 publication Critical patent/ATE227346T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
AT96914259T 1995-05-02 1996-04-29 Verfahren zur spezifischen kopplung einer schutzgruppe an das 5'-ende eines mrna-fragmentes und die herstellung von mrna und vollständiger cdna ATE227346T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9505221A FR2733765B1 (fr) 1995-05-02 1995-05-02 Methode de couplage specifique de la coiffe de l'extremite 5' d'un fragment d'arnm
FR9509467A FR2733762B1 (fr) 1995-05-02 1995-08-03 Methode de couplage specifique de la coiffe de l'extremite 5' d'un fragment d'arnm et preparation d'arnm et d'adnc complet
PCT/FR1996/000651 WO1996034981A2 (fr) 1995-05-02 1996-04-29 METHODE DE COUPLAGE SPECIFIQUE DE LA COIFFE DE L'EXTREMITE 5' D'UN FRAGMENT D'ARNm ET PREPARATION D'ARNm ET D'ADNc COMPLET

Publications (1)

Publication Number Publication Date
ATE227346T1 true ATE227346T1 (de) 2002-11-15

Family

ID=26231928

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96914259T ATE227346T1 (de) 1995-05-02 1996-04-29 Verfahren zur spezifischen kopplung einer schutzgruppe an das 5'-ende eines mrna-fragmentes und die herstellung von mrna und vollständiger cdna

Country Status (12)

Country Link
US (1) US6022715A (de)
EP (1) EP0824598B1 (de)
JP (1) JPH11510364A (de)
AT (1) ATE227346T1 (de)
AU (1) AU719217B2 (de)
CA (1) CA2220045C (de)
DE (1) DE69624695T2 (de)
DK (1) DK0824598T3 (de)
ES (1) ES2186778T3 (de)
FR (1) FR2733762B1 (de)
PT (1) PT824598E (de)
WO (1) WO1996034981A2 (de)

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766891A (en) 1994-12-19 1998-06-16 Sloan-Kettering Institute For Cancer Research Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase
JP3441899B2 (ja) * 1996-11-01 2003-09-02 理化学研究所 完全長ｃＤＮＡライブラリーの作成方法
CA2263716C (en) 1997-06-12 2007-09-25 Sloan-Kettering Institute For Cancer Research Covalent joining of dna strands to rna strands catalyzed by vaccinia topoisomerase
PT1000149E (pt) * 1997-08-01 2007-08-03 Serono Genetics Inst Sa 5' ests para proteínas segregadas identificadas a partir de tecidos do cérebro.
US6222029B1 (en) 1997-08-01 2001-04-24 Genset 5′ ESTs for secreted proteins expressed in brain
PT1375514E (pt) * 1997-08-01 2006-10-31 Serono Genetics Inst Sa Ests 5' para proteinas secretadas expressas em varios tecidos
EP1367124A1 (de) * 1997-08-01 2003-12-03 Genset 5' Ests für sekretierte Proteine, die im Muskel und anderen mesodermalen Geweben exprimiert werden
US7393663B2 (en) 1997-08-01 2008-07-01 Serono Genetics Institute S.A. Expressed sequence tags and encoded human proteins
JP2001512013A (ja) * 1997-08-01 2001-08-21 ジェンセット 前立腺に発現される分泌タンパク質の５’ｅｓｔ
JP2001512005A (ja) * 1997-08-01 2001-08-21 ジェンセット 内胚葉において発現する分泌タンパク質の５’ｅｓｔ
ATE338117T1 (de) * 1997-08-01 2006-09-15 Serono Genetics Inst Sa 5' ests für proteine, die nicht gewebespezifisch sind
JP2001512012A (ja) * 1997-08-01 2001-08-21 ジェンセット 精巣およびその他の組織で発現する分泌タンパク質の５’ｅｓｔ
FR2767135B1 (fr) 1997-08-06 2002-07-12 Genset Sa Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
CA2306777A1 (en) * 1997-10-22 1999-04-29 Helix Research Institute Method for screening full-length cdna clones
US6312922B1 (en) * 1998-02-09 2001-11-06 Genset Complementary DNAs
US6573068B1 (en) 1997-11-13 2003-06-03 Genset, S. A. Claudin-50 protein
US6548633B1 (en) 1998-12-22 2003-04-15 Genset, S.A. Complementary DNA's encoding proteins with signal peptides
US20060286639A1 (en) * 1997-11-13 2006-12-21 Serono Genetics Institute S.A. Complementary DNAs encoding proteins with signal peptides
EP1029045A2 (de) * 1997-11-13 2000-08-23 Genset VERLÄNGERTE cDNAs, DIE FÜR SEKRETIERTE PROTIEINE KODIEREN
EP1903111A3 (de) * 1997-11-13 2008-07-02 Serono Genetics Institute S.A. Erweiterte cDNA für sekretierte Proteine
AU758004B2 (en) * 1997-12-17 2003-03-13 Genset S.A. Extended cDNAs for secreted proteins
US6783961B1 (en) 1999-02-26 2004-08-31 Genset S.A. Expressed sequence tags and encoded human proteins
JP2002511259A (ja) 1998-04-09 2002-04-16 ジェンセット ５’ｅｓｔおよびコードされるヒトタンパク質
US7223727B2 (en) 1998-04-09 2007-05-29 Serono Genetics Institute S.A. GSSP4 polynucleotides and polypeptides and uses thereof
ATE397064T1 (de) 1998-11-04 2008-06-15 Serono Genetics Inst Sa Genomische und vollständige cdna sequenzen von menschlichem adipozyten spezifischem apm1 und biallelische marker davon
US6455280B1 (en) 1998-12-22 2002-09-24 Genset S.A. Methods and compositions for inhibiting neoplastic cell growth
DE60041912D1 (de) 1999-02-10 2009-05-14 Serono Genetics Inst Sa Polymorphe marker des lsr-gens
EP1586645A3 (de) 1999-02-25 2006-02-22 Ceres Incorporated DNA-Fragmente mit bestimmter Sequenz und die dadurch kodierte Polypeptide
EP1165768A1 (de) * 1999-03-19 2002-01-02 Invitrogen Corporation Methode zur herstellung nucleinsäuresequenzen voller länge mittels topoisomerase iii aus e. coli und ihren homologen
AU3763200A (en) * 1999-03-19 2000-10-09 Genetics Institute Inc. Primers-attached vector elongation (pave): a 5'-directed cdna cloning strategy
US7485715B2 (en) 1999-06-18 2009-02-03 Ceres, Inc. Sequence-determined DNA encoding AP2 domain polypeptides
US7479555B2 (en) 1999-07-21 2009-01-20 Ceres, Inc. Polynucleotides having a nucleotide sequence that encodes a polypeptide having MOV34 family activity
CA2311201A1 (en) * 1999-08-05 2001-02-05 Genset S.A. Ests and encoded human proteins
US7338787B2 (en) 2000-01-14 2008-03-04 Serono Genetics Institute S.A. Nucleic acids encoding OBG3 globular head and uses thereof
US20020058617A1 (en) 2000-01-14 2002-05-16 Joachim Fruebis OBG3 globular head and uses thereof for decreasing body mass
US6566332B2 (en) 2000-01-14 2003-05-20 Genset S.A. OBG3 globular head and uses thereof for decreasing body mass
US6989367B2 (en) 2000-01-14 2006-01-24 Genset S.A. OBG3 globular head and uses thereof
US7078501B2 (en) 2000-02-25 2006-07-18 Invitrogen Corporation Topoisomerase linker-mediated amplification methods
US6387624B1 (en) * 2000-04-14 2002-05-14 Incyte Pharmaceuticals, Inc. Construction of uni-directionally cloned cDNA libraries from messenger RNA for improved 3′ end DNA sequencing
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US6916632B2 (en) 2000-08-21 2005-07-12 Invitrogen Corporation Methods and reagents for molecular cloning
US6875907B2 (en) 2000-09-13 2005-04-05 Pioneer Hi-Bred International, Inc. Antimicrobial peptides and methods of use
NZ526194A (en) 2000-12-08 2004-10-29 Invitrogen Corp Methods of covalently linking, in one or both strands, two or more double stranded nucleotide sequences using one or more topoisomerases
US20060008817A1 (en) 2000-12-08 2006-01-12 Invitrogen Corporation Methods and compositions for generating recombinant nucleic acid molecules
AU2002331897A1 (en) 2001-09-27 2003-04-07 Pioneer Hi-Bred International, Inc. Phytate polynucleotides and methods of use
WO2003087313A2 (en) 2002-04-08 2003-10-23 Pioneer Hi-Bred International, Inc. Enhanced silk exsertion under stress
US20050250100A1 (en) * 2002-06-12 2005-11-10 Yoshihide Hayashizaki Method of utilizing the 5'end of transcribed nucleic acid regions for cloning and analysis
EP1616947B1 (de) * 2003-03-28 2012-05-09 Japan as represented by Director General of National Rehabilitation Center for Persons with Disabilities VERFAHREN ZUR SYNTHESE VON cDNA
DE602004027538D1 (de) 2003-12-01 2010-07-15 Life Technologies Corp Rekombinationsstellen enthaltende nukleinsäuremoleküle und verfahren zur verwendung davon
GB0417887D0 (en) * 2004-08-11 2004-09-15 Ares Trading Sa Protein
US8206924B2 (en) * 2006-09-11 2012-06-26 Osaka University Trace mRNA amplification method and use thereof
BRPI0819743A2 (pt) 2007-11-20 2014-10-07 Pioneer Hi Bred Int Ácido nucléico isolado, cassete de expressão, célula hospedeira, planta transgênica, semente transgênica, método para modular a resposta de etileno em uma planta, proteína isolada
US20100035249A1 (en) * 2008-08-05 2010-02-11 Kabushiki Kaisha Dnaform Rna sequencing and analysis using solid support
US8716553B2 (en) 2009-03-02 2014-05-06 Pioneer Hi Bred International Inc NAC transcriptional activators involved in abiotic stress tolerance
WO2011017492A2 (en) 2009-08-05 2011-02-10 Pioneer Hi-Bred International, Inc. Novel eto1 genes and use of same for reduced ethylene and improved stress tolerance in plants
CA2807552A1 (en) 2010-08-06 2012-02-09 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
EP2857499A1 (de) 2010-10-01 2015-04-08 Moderna Therapeutics, Inc. Manipulierte Nukleinsäuren und Verfahren zur Verwendung davon
CA2831613A1 (en) 2011-03-31 2012-10-04 Moderna Therapeutics, Inc. Delivery and formulation of engineered nucleic acids
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
PT3682905T (pt) 2011-10-03 2022-04-07 Modernatx Inc Nucleósidos, nucleótidos e ácidos nucleicos modificados e respetivas utilizações
US20150082480A1 (en) 2011-10-25 2015-03-19 Pioneer Hi Bred International Inc Methods to alter plant cell wall composition for improved biofuel production and silage digestibility
ES2923757T3 (es) 2011-12-16 2022-09-30 Modernatx Inc Composiciones de ARNm modificado
WO2013151664A1 (en) 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of proteins
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US10501512B2 (en) 2012-04-02 2019-12-10 Modernatx, Inc. Modified polynucleotides
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
EP2684954A1 (de) 2012-07-10 2014-01-15 Lexogen GmbH 5'-schutzabhängige Verstärkung
US9422602B2 (en) * 2012-08-15 2016-08-23 Bio-Rad Laboratories, Inc. Methods and compositions for determining nucleic acid degradation
PT2922554T (pt) 2012-11-26 2022-06-28 Modernatx Inc Arn modificado nas porções terminais
EP2971033B8 (de) 2013-03-15 2019-07-10 ModernaTX, Inc. Herstellungsverfahren zur herstellung von rna-transkripten
WO2014144767A1 (en) 2013-03-15 2014-09-18 Moderna Therapeutics, Inc. Ion exchange purification of mrna
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
EP4279610A3 (de) 2013-03-15 2024-01-03 ModernaTX, Inc. Ribonukleinsäurereinigung
WO2014152507A2 (en) 2013-03-15 2014-09-25 Pioneer Hi-Bred International, Inc. Modulation of acc deaminase expression
US10077439B2 (en) 2013-03-15 2018-09-18 Modernatx, Inc. Removal of DNA fragments in mRNA production process
PL3019619T3 (pl) 2013-07-11 2022-01-10 Modernatx, Inc. Kompozycje zawierające syntetyczne polinkleotydy kodujące białka powiązane z crispr i syntetyczne sgrna oraz sposoby ich stosowania
US10023626B2 (en) 2013-09-30 2018-07-17 Modernatx, Inc. Polynucleotides encoding immune modulating polypeptides
EP3052511A4 (de) 2013-10-02 2017-05-31 Moderna Therapeutics, Inc. Polynukleotidmoleküle und verwendungen davon
KR20160067219A (ko) 2013-10-03 2016-06-13 모더나 세라퓨틱스, 인코포레이티드 저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
US11479766B2 (en) * 2013-12-05 2022-10-25 New England Biolabs, Inc. Methods for labeling a population of RNA molecules
AU2015289656A1 (en) 2014-07-16 2017-02-16 Modernatx, Inc. Circular polynucleotides
EP4101930A1 (de) 2015-09-17 2022-12-14 ModernaTX, Inc. Polynukleotide mit stabilisierendem schwanzbereich
WO2017049286A1 (en) 2015-09-17 2017-03-23 Moderna Therapeutics, Inc. Polynucleotides containing a morpholino linker
US11866754B2 (en) 2015-10-16 2024-01-09 Modernatx, Inc. Trinucleotide mRNA cap analogs
DK3362461T3 (da) 2015-10-16 2022-05-09 Modernatx Inc Mrna-cap-analoger med modificeret phosphatbinding
WO2017130750A1 (ja) 2016-01-27 2017-08-03 株式会社ダナフォーム Ｒｎａの末端領域に対応する核酸の塩基配列を解読する方法およびｄｎａエレメントの分析方法
US12385034B2 (en) 2016-06-24 2025-08-12 Modernatx, Inc. Methods and apparatus for filtration
SG11201901941YA (en) 2016-09-14 2019-04-29 Modernatx Inc High purity rna compositions and methods for preparation thereof
EP3668977A4 (de) 2017-08-18 2021-04-21 Modernatx, Inc. Analytische hplc-verfahren
WO2019036685A1 (en) 2017-08-18 2019-02-21 Modernatx, Inc. METHODS FOR HPLC ANALYSIS
MX2021011031A (es) 2019-03-11 2021-12-10 Modernatx Inc Proceso de transcripción in vitro en lotes alimentados.
WO2022150717A1 (en) 2021-01-11 2022-07-14 Modernatx, Inc. Seasonal rna influenza virus vaccines
US20250122546A1 (en) 2021-10-28 2025-04-17 BioNTech SE Rna constructs and uses thereof
WO2023127774A1 (ja) * 2021-12-28 2023-07-06 株式会社ダナフォーム 遺伝子包含体の検出方法及び検出用キット
WO2023237703A1 (en) 2022-06-09 2023-12-14 Vestlandets Innovasjonsselskap As Method of characterizing capped rna
CN115896239A (zh) * 2022-07-25 2023-04-04 四川康德赛医疗科技有限公司 一种rna修饰效率的定量方法、试剂盒及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661450A (en) * 1983-05-03 1987-04-28 Molecular Genetics Research And Development Limited Partnership Molecular cloning of RNA using RNA ligase and synthetic oligonucleotides
US4710566A (en) * 1984-12-27 1987-12-01 Yale University Purification of the messenger RNA cap-binding protein
US5273879A (en) * 1987-07-23 1993-12-28 Syntex (U.S.A.) Inc. Amplification method for polynucleotide assays
US5219989A (en) * 1988-12-13 1993-06-15 Mcgill University Bifunctional protein for the isolation of capped mRNA
CA2005252C (en) * 1988-12-13 2001-07-17 Nahum Sonenberg Isolation of full-length cdna clones and capped mrna
US5324829A (en) * 1988-12-16 1994-06-28 Ortho Diagnostic Systems, Inc. High specific activity nucleic acid probes having target recognition and signal generating moieties
JP3315439B2 (ja) * 1992-07-21 2002-08-19 住友電気工業株式会社 細胞特異的ｃＤＮＡの分離法及びライブラリー作製法
JP3337748B2 (ja) * 1992-09-25 2002-10-21 財団法人神奈川科学技術アカデミー 完全長ｃＤＮＡの合成方法、その中間体の製造方法及び完全長ｃＤＮＡを含む組換えベクターの製造方法

Also Published As

Publication number Publication date
US6022715A (en) 2000-02-08
ES2186778T3 (es) 2003-05-16
WO1996034981A2 (fr) 1996-11-07
FR2733762B1 (fr) 1997-08-01
PT824598E (pt) 2003-03-31
JPH11510364A (ja) 1999-09-14
DK0824598T3 (da) 2003-03-10
CA2220045C (fr) 2001-10-30
CA2220045A1 (fr) 1996-11-07
DE69624695D1 (de) 2002-12-12
WO1996034981A3 (fr) 1997-01-03
EP0824598A2 (de) 1998-02-25
DE69624695T2 (de) 2003-07-31
AU719217B2 (en) 2000-05-04
EP0824598B1 (de) 2002-11-06
FR2733762A1 (fr) 1996-11-08
AU5982996A (en) 1996-11-21

Similar Documents

Publication Publication Date Title
DE69624695D1 (de) VERFAHREN ZUR SPEZIFISCHEN KOPPLUNG EINER SCHUTZGRUPPE AN DAS 5'-ENDE EINES mRNA-FRAGMENTES UND DIE HERSTELLUNG VON mRNA UND VOLLSTÄNDIGER cDNA
ATE167848T1 (de) Aerogelhaltige zusammensetzung, verfahren zur ihrer herstellung sowie ihre verwendung
DE69716767D1 (de) Verfahren zur herstellung von tolterodin
EP0767657A4 (de) Neues verfahren zur herstellung von bekannten und neuen 2'-modifizierten nukleosiden durch intramolekulare nukleophile substitution
DE50115872D1 (de) Verfahren zur herstellung eines bioanalytischen reagenzes, nachweisverfahren beruhend auf der verwendung des bioanalytischen reagenz, sowie dessen verwendung
DE50008164D1 (de) Galactomannan-oligosaccharide und verfahren zu deren herstellung sowie deren verwendung
ATE266030T1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
DE69527876D1 (de) Zwischenprodukte für die Herstellung von Pyrazoloazolen als fotografische Kuppler, Verfahren zu ihrer Herstellung und ihre Verwendung
DE60011396D1 (de) Verfahren zur herstellung von iopamidol
DE59602230D1 (de) Verfahren zur Herstellung von 2,2-Difluorbenzo[1.3]dioxolcarbaldehyden
DE69522436D1 (de) Verfahren zur herstellung von äthylalkohol
ATE187440T1 (de) Verfahren zur herstellung von substituierten 3- aminobenzonitrilen
ATE253568T1 (de) Verfahren zur herstellung von citalopram
DE69517191D1 (de) Wasserlösliche derivate epipodophyllotoxine, verfahren zu ihrer herstellung, ihre verwendung als medikament und ihre verwendung zur herstellung eines antikrebsmittels
ATE252543T1 (de) Verfahren zur herstellung chiraler (s)-2,3- disubstituierter 1-propylamin-derivate
ATE308571T1 (de) Verfahren zur herstellung von hydrierten aromatischen polymerzusammensetzungen
ATE207880T1 (de) Verfahren zur herstellung von kontrastmitteln
DE59705787D1 (de) Verfahren zur herstellung von n,n'-dialkylperylen-3,4,9,10-tetracarbonsäurediimiden
DE69514122D1 (de) Lösungsmittelfreies verfahren zur herstellung von 2,6 difluorbenzonitril
ATE189677T1 (de) Verfahren zur herstellung von furosemide
DE60003807D1 (de) Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung
ATE205473T1 (de) Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
DE69835903D1 (de) VERFAHREN FÜR DIE HERSTELLUNG VON iS,Sö-ETHYLENDIAMIN-N,N'-DI-BERNSTEINSÄURE
ATE215552T1 (de) Verfahren zur herstellung von ivermectin
DE69504188D1 (de) Verfahren zur herstellung von 5-amino-1,3-dioxanen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0824598

Country of ref document: EP

REN Ceased due to non-payment of the annual fee